DOCS

Doximity, Inc. (DOCS) stock has experienced significant volatility in the past six months. The share price saw a substantial decline of 55.98% from May 7, 2025, to May 6, 2026, and was down approximately 41.3% year-to-date in 2026. In February 2026, Doximity reported Q3 fiscal 2026 results that beat Wall Street's expectations, but the stock plummeted due to weaker-than-expected Q4 fiscal 2026 revenue guidance attributed to industry-wide policy headwinds, specifically Most Favored Nation agreements. The resignation of CFO Anna Bryson further contributed to investor uncertainty. Despite these challenges, the company's board authorized a new $500 million share repurchase program.